ReviewBrain : a journal of neurology2026
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease.
Review in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Monocyte-derived cells (MCs) are highly adaptable innate immune cells that play essential roles in CNS inflammation. Their functional specialization is closely linked to their metabolic state, which is shaped by local cues such as nutrient availability, oxygen levels and pro- and anti-inflammatory signals. In this review, we examine the major metabolic pathways that regulate MC behaviour, including glycolysis, oxidative phosphorylation, lipid metabolism and amino acid metabolism. We assess how these pathways support specific effector functions such as cytokine production, phagocytosis, antigen presentation and efferocytosis. Moving beyond the traditional pro-/anti-inflammatory (M1/M2) framework, we discuss the context-dependent nature of MC metabolism and its role in driving diverse functional states. We then explore how these metabolic programmes are engaged across key CNS disease settings, including sterile injury, demyelinating disease and viral encephalitis. By integrating insights from immunometabolism and neuroinflammation, this review provides a framework for understanding the metabolic regulation of MCs in CNS pathology and highlights potential avenues for therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.